Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen C Bain

Showing results (21-30 of 129) with videos related to

Pageof 13
Sort By:
Atherosclerosis|July 22, 2008
The biological relevance and measurement of plasma markers of oxidative stress in diabetes and cardiovascular diseaseJeffrey W Stephens, Manish P Khanolkar, Stephen C Bain
Touchreviews in Endocrinology|August 17, 2022
Glucagon-like Peptide-1 Receptor Analogues for the Treatment of ObesityDavid M Williams, Matthew Staff, Stephen C Bain, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 17, 2011
Irbesartan delays progression of nephropathy as measured by estimated glomerular filtration rate: post hoc analysis of the Irbesartan Diabetic Nephropathy TrialMarc Evans, Stephen C Bain, Simon Hogan, et al.
Plos One|April 22, 2016
Molecular Characterisation of Small Molecule Agonists Effect on the Human Glucagon Like Peptide-1 Receptor InternalisationAiysha Thompson, Jeffrey W Stephens, Stephen C Bain, et al.
Diabetes, Obesity & Metabolism|September 19, 2018
Worsening of diabetic retinopathy with rapid improvement in systemic glucose control: A reviewStephen C Bain, Michael A Klufas, Allen Ho, et al.
European Journal of Sport Science|September 28, 2024
Continuous measurement of interstitial glycaemia in professional female UCI world tour cyclists undertaking a 9-day cycle training campRoss Hamilton, Olivia M McCarthy, Stephen C Bain, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|November 27, 2018
Efficacy and Safety of IDegAsp Versus BIAsp 30, Both Twice Daily, in Elderly Patients with Type 2 Diabetes: Post Hoc Analysis of Two Phase 3 Randomized Controlled BOOST TrialsGreg Fulcher, Roopa Mehta, Edmond G Fita, et al.
Current Diabetes Reports|April 12, 2007
Gene discovery in diabetic nephropathyDavid A Savage, Stephen C Bain, Amy Jayne McKnight, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 26, 2021
Glucagon-Like Peptide 1 Receptor Agonist Usage in Type 2 Diabetes in Primary Care for the UK and Beyond: A Narrative ReviewKevin Fernando, Stephen C Bain, Patrick Holmes, et al.
Journal of Medical Economics|July 18, 2019
Evaluating the burden of poor glycemic control associated with therapeutic inertia in patients with type 2 diabetes in the UKStephen C Bain, Brian Bekker Hansen, Barnaby Hunt, et al.
Pageof 13

Showing results (21-30 of 129) with videos related to

Sort By:
Pageof 13
Atherosclerosis|July 22, 2008
The biological relevance and measurement of plasma markers of oxidative stress in diabetes and cardiovascular diseaseJeffrey W Stephens, Manish P Khanolkar, Stephen C Bain
Touchreviews in Endocrinology|August 17, 2022
Glucagon-like Peptide-1 Receptor Analogues for the Treatment of ObesityDavid M Williams, Matthew Staff, Stephen C Bain, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 17, 2011
Irbesartan delays progression of nephropathy as measured by estimated glomerular filtration rate: post hoc analysis of the Irbesartan Diabetic Nephropathy TrialMarc Evans, Stephen C Bain, Simon Hogan, et al.
Plos One|April 22, 2016
Molecular Characterisation of Small Molecule Agonists Effect on the Human Glucagon Like Peptide-1 Receptor InternalisationAiysha Thompson, Jeffrey W Stephens, Stephen C Bain, et al.
Diabetes, Obesity & Metabolism|September 19, 2018
Worsening of diabetic retinopathy with rapid improvement in systemic glucose control: A reviewStephen C Bain, Michael A Klufas, Allen Ho, et al.
European Journal of Sport Science|September 28, 2024
Continuous measurement of interstitial glycaemia in professional female UCI world tour cyclists undertaking a 9-day cycle training campRoss Hamilton, Olivia M McCarthy, Stephen C Bain, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|November 27, 2018
Efficacy and Safety of IDegAsp Versus BIAsp 30, Both Twice Daily, in Elderly Patients with Type 2 Diabetes: Post Hoc Analysis of Two Phase 3 Randomized Controlled BOOST TrialsGreg Fulcher, Roopa Mehta, Edmond G Fita, et al.
Current Diabetes Reports|April 12, 2007
Gene discovery in diabetic nephropathyDavid A Savage, Stephen C Bain, Amy Jayne McKnight, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 26, 2021
Glucagon-Like Peptide 1 Receptor Agonist Usage in Type 2 Diabetes in Primary Care for the UK and Beyond: A Narrative ReviewKevin Fernando, Stephen C Bain, Patrick Holmes, et al.
Journal of Medical Economics|July 18, 2019
Evaluating the burden of poor glycemic control associated with therapeutic inertia in patients with type 2 diabetes in the UKStephen C Bain, Brian Bekker Hansen, Barnaby Hunt, et al.
Pageof 13